Welcome to NC Community Colleges BioNetwork
RALEIGH, N.C. (October 10, 2013) - The BioNetwork Capstone Center held an open house Thursday, October 10, and more than 100 industry professionals and job seekers gathered for a behind-the-scenes look at the simulated biomanufacturing facility. “We were thrilled to showcase our hands-on facility for industry leaders, and to highlight the broad spectrum of customized training and short-course certificate programs we offer at Wake Tech,” said Ana McClanahan, dean of the BioNetwork Capstone Center.Read more...
The new Pipetting eLearning tool was exhibited at SolutionFest 2013, an annual showcase of eLearning solutions developed by organizations from across the world. Pipetting was voted Best of Show in the Non-Vendor category!
You've just been hired as a quality assurance inspector for a research testing company. Your job is to talk to employees in the aliquoting department and identify pipetting-related CAPA, Corrective and Preventative Actions that your company should take.
Click here to check out our newest interactive eLearning tool.Read more...
The North Carolina Community College System offers a wide variety of life science educational and industrial training opportunities throughout the state. Search the following categories to find the opportunity that best fits your needs.
Search Our Online Catalog
Interactive E-Learning Tools
Try your hand at operating a virtual centrifuge, gowning for the cleanroom, or practice lab safety through these exciting and interactive e-learning tools. Read more...
BioNetwork's YouTube channel features over 70 videos to help learners prepare for a hands-on lab experience. Watch the procedure, then do it yourself! Read more...
The Gulf state of Qatar on Tuesday launched a genetic code mapping project for its small population to help in treating diseases. The "Qatar Genome" project is a "road map for future treatment," said Sheikha Moza bint Nasser, the wife of the former emir, at the opening of the World Innovation Summit for Health in Doha. Qatar has a population of 2.1 million, including some 300,000 Qatari nationals. Neighbouring Saudi Arabia announced on Sunday launching a genetic code mapping project aimed at identifying the basis of chronic diseases prevalent in the desert kingdom.
Saudi Arabia has launched a genetic code mapping project aimed at identifying the basis of chronic diseases prevalent in the desert kingdom. The Saudi Human Genome Program will be run by Saudi researchers, in cooperation with the US Life Technologies Corporation, at the King Abdulaziz City for Science and Technology (KACST). "The programme aims to identify the causes of prevalent chronic diseases in Saudi Arabia," Prince Moqrin bin Abdul Aziz, the second deputy prime minister, said Sunday. The programme will work over five years on sequencing 100,000 human genomes to study both normal and disease-associated genes specific to the Saudi population, said a statement by Life Technologies.
These cheaper versions of expensive biotech drugs, known as biosimilars, could slash the cost of treating diseases like cancer and rheumatoid arthritis in the same way that generics have curbed spending on traditional medicines. But although Europe has pioneered their path to market - approving the first biosimilar drug in 2006 and the latest, an antibody drug from U.S.-based Hospira and Celltrion of South Korea, in September - uptake has been patchy. Norway hopes to kick-start uptake of these products by funding clinical studies in which patients will be switched from original drugs to biosimilars in order to reassure doctors that the copycat versions are just as good. The 2014 Norwegian studies will compare Johnson & Johnson's and Merck & Co's Remicade drug for rheumatoid arthritis - which sold more than $2 billion in Europe last year - to Hospira and Celltrion's new copy, Inflectra.
(Reuters) - Home genetic test maker 23andMe, which is backed by Google Inc, stopped marketing its products last week after the U.S. Food and Drug Administration warned that it did not have regulatory approval to do so, a company spokeswoman said. The FDA said last week it had sent a warning letter to the company on November 22 stating that products designed to diagnose, mitigate or prevent disease were medical devices that required regulatory clearance. Company founder Anne Wojcicki said in a November 26 blog post that the company had been talking to the FDA since 2008 and had submitted its first application for clearance in July last year, followed by another submission in September. "We stand behind the data that we return to customers - but we recognize that the FDA needs to be convinced of the quality of our data as well," Wojcicki wrote in the post.
BioNetwork supports the mission of the North Carolina Community College System (NCCCS) aligning world class workforce training and education to the Biotechnology, pharmaceutical and life science industries. BioNetwork trains at all levels of this industry, upgrading the skills of incumbent workers, from entry level to management. Our seven centers, strategically and geographically positioned, develop short and curriculum designed courses to meet the needs of industry. The centers themselves are staffed with highly skilled industry trained experts that are constantly developing workforce training programs that can be delivered anywhere in North Carolina.